Three-dimensional (3D) brain organoids derived from human pluripotent stem cells (hPSCs), including human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs), have become a powerful system to study early development events and to model human disease. Cerebral organoids are generally produced in static culture or in a culture vessel with active mixing, and the two most widely used systems for mixing are a large spinning flask and a miniaturized multi-well spinning bioreactor (also known as Spin Omega (SpinΩ)). The SpinΩ provides a system that is amenable to drug testing, has increased throughput and reproducibility, and utilizes less culture media. However, technical limitations of this system include poor stability of select components and an elevated risk of contamination due to the inability to sterilize the device preassembled. Here, we report a new design of the miniaturized bioreactor system, which we term Spin∞ that overcomes these concerns to permit long-term experiments.Brain organoids are three-dimensional (3D) structures formed from neural stem cells (NSCs) derived from human pluripotent stem cells (hPSCs) that can effectively model human brain development up to 12-14 weeks post-conception [1-4], a time period which includes critical patterning events in the cerebral cortex and other brain regions [5,6]. On a cellular level, brain organoids show a high level of similarity to the in vivo developing human brain in the early stages of development, including progenitor zones (ventricular zone and subventricular zone consisting of PAX6+/SOX2+ NSCs) that form around central lumens [1,4].These 3D organoid cultures therefore provide a robust system amenable to extended cultivation and manipulation, which makes them a useful tool to model development and disease in the context of the complex brain microenvironment [7][8][9].Recently, two protocols have been published on enhancing cortical plate formation within hPSC-derived cerebral organoids: one using large spinner flasks and microfilaments as a solid support [1,10] and another that uses a miniature spinning bioreactor termed Spin Omega (SpinΩ) [11,12], which consists of 3D printed gears and paddles driven by a single electric motor. The SpinΩ provide an accessible and versatile format for culturing brain-region-specific organoids due to its reduced incubator footprint, decreased media consumption, and increased throughput, but several technical caveats limit its use in long-term experiments, most prominently the choice of components used to fabricate the device and the design of the device with respect to limiting the chances of contamination and mechanical failure. Here, we redesigned the SpinΩ to overcome these problems, leading to the creation of a device that we have termed Spinfinity (Spin∞).